Navigation Links
Access Pharmaceuticals Provides Second Quarter Update on MuGard Commercial Activities
Date:8/16/2011

DALLAS and NEW YORK, Aug. 16, 2011 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, has announced its second quarter 2011 investor conference call and the recent progress in its MuGard program.   MuGard is a mucoadhesive oral wound rinse and coating that has been shown to be very effective in the management of oral mucositis, a debilitating side effect of many anticancer treatments.  The investor conference call is scheduled to be held on Wednesday, September 7, 2011 at 11:00 am EDT.  Interested parties may participate by dialing 877-407-4019 (US) or 201-689-8337 (International) approximately five to ten minutes before the call start time.  

Second Quarter 2011 Highlights:

  • Payer Uptake Accelerates: Throughout the second quarter, Access made significant progress in increasing reimbursement for MuGard throughout the U.S.  From pharmacy benefit manager (PBM), CVS Caremark, to insurance payers like, TRICARE, Humana, United Healthcare, Harvard Pilgrim, SummaCare, Amerigroup and several Blue Cross Blue Shield state plans, reimbursement for MuGard is available for over 65 million lives and growing.

  • MuGard PRSC: In mid-July, Access launched the MuGard Patient Reimbursement and Support Center (PRSC), also known as the MuGard HUB, to serve as a centralized patient referral center that improves patient access to MuGard by enhancing product distribution and facilitating payment for MuGard by insurance carriers.  The MuGard HUB is handling reimbursement currently, and having success with both private payers as well as supplemental insurance plans of Medica
    '/>"/>

  • SOURCE Access Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. HeartWare to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference
    2. Pacira Pharmaceuticals, Inc. to Present at Wedbush Securities 2011 Life Sciences Management Access Conference
    3. Lexicon Pharmaceuticals to Present at the Wedbush 2011 Life Sciences Management Access Conference
    4. Savient Pharmaceuticals to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference
    5. Market Research Structures and Activities That Optimize Payer Access & Insights
    6. Access Pharmaceuticals Expands its MuGard Specialty Pharmacy Reach With Community Specialty Pharmacy Network
    7. Ikaria® to Present at 2011 Wedbush Life Sciences Management Access Conference
    8. Cardica to Present at the Wedbush Life Sciences Management Access Conference
    9. Access Pharmaceuticals Retains Edelman as Public Relations Firm
    10. Unrestricted Access to Advanced Imaging a Top Priority for Consumers
    11. Elsevier Launches Next Generation Codifa, Providing Italian Doctors with Real Time Access to Critical Drug Information
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/6/2015)... and FARMINGTON, Conn. , ... MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific ... significant unmet medical need and commercial potential, today ... placement of Series E warrants to purchase 21,917,808 ... warrants to purchase 2,191,781 shares of its common ...
    (Date:7/6/2015)... , July 6, 2015  Impax Laboratories, Inc. ... Hsu , Ph.D. has resigned from the Company,s Board ... Dr. Hsu was a co-founder of Impax in 1995 ... Officer from October 2006 until April 2014. ... Wilkinson , Impax,s President and Chief Executive Officer stated, ...
    (Date:7/6/2015)... DIEGO , July 6, 2015  OncoSec Medical ... DNA-based intratumoral cancer immunotherapies, today announced the appointment of ... position of Vice President of Market Development, effective July ... responsible for evaluating, designing, and executing on the company,s ... "I,m very excited to welcome Joann to ...
    Breaking Medicine Technology:Palatin Technologies Completes $30 Million Financing 2Palatin Technologies Completes $30 Million Financing 3Palatin Technologies Completes $30 Million Financing 4Palatin Technologies Completes $30 Million Financing 5Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 2Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 3Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 4Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 5OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development 2OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development 3
    ... production, increasing blood ... flow, muscle oxygen supply, HOBOKEN, N.J., Oct. ... Hypertension Research reveals Pycnogenol(R),(pic-noj-en-all), an antioxidant plant extract from the bark ... oxide,(NO) production which leads to an increase in blood flow and ...
    ... Developed Through Joint Venture Between Bristol-Myers Squibb, ... Its Kind in HIV Treatment -, PRINCETON, ... Bristol-Myers Squibb Company (NYSE: BMY ) and ... that Health Canada has approved ATRIPLA(R),(efavirenz 600 mg/emtricitabine ...
    Cached Medicine Technology:New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production 2New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production 3Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 2Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 3Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 4Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 5Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 6Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 7Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 8Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 9
    (Date:7/5/2015)... (PRWEB) , ... July 06, 2015 , ... ... ancillary benefits market, is excited to announce the next generation of PrimeStar Individual ... Advantage plans to now include two network options—Maximum Allowable Charge (MAC) and usual, ...
    (Date:7/5/2015)... ... 05, 2015 , ... Doctors at the Swedish Cancer Institute in Seattle, Washington ... change the outlook for people with pleural mesothelioma. Surviving Mesothelioma has just posted the ... that five mesothelioma patients treated with 25Gy of radiation over five days just prior ...
    (Date:7/4/2015)... California (PRWEB) , ... July 04, 2015 , ... ... earned the solar industry’s leading recognition of technical sales expertise from the North ... PV Technical Sales ProfessionalTM. NABCEP is the most highly respected and well established ...
    (Date:7/3/2015)... ... ... at several top US cancer centers believe they now know why certain people are ... the complete story , just posted on the Surviving Mesothelioma website. , Researchers ... University exposed mice with a mutation on the tumor suppressor gene called BAP1 to ...
    (Date:7/3/2015)... ... 03, 2015 , ... Smoothies are all the rage right now and all ... quality ingredients. Aurora Natural is proud to introduce a new line of all natural ... antioxidants, vitamins and minerals! , Aurora is offering a variety of blends and stand-alone ...
    Breaking Medicine News(10 mins):Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2Health News:New Mesothelioma Study Calls IMRT/Surgery Combo “Innovative and Promising”, According to Surviving Mesothelioma 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2
    ... donor egg availability and lower cost, innovative IVF financing options ... more couples from the United Kingdom are crossing the ocean ... www.shadygrovefertility.com ), the Washington/Baltimore area,s largest in ... five dozen British patients received IVF treatment there last year, ...
    ... Take Basic Preparedness Steps for Hurricane and Flu Seasons , ... people were affected by disaster than any year in the previous ... the next six months, as the United States and the Caribbean ... flu, response organizations are preparing for the possibility of an even ...
    ... Genomics Research Institute (TGen) scientists have identified five genetic ... fewer side-effects, for patients with diabetes. TGen Senior ... Orleans on June 6, 2009, at the 69th Scientific ... genetic variants that may predict how well someone will ...
    ... Serves Growing Non-Urban Market Segments , , ... ("Global Med" or the "Company") (OTC Bulletin Board: ... announced that its Wyndgate Technologies(R) division has licensed ... 40+ hospital healthcare system. The organization will ...
    ... ORANGE, Fla., June 16 Suddenly it happens, with the ... ourselves needing to parent our parents. , , Author ... Dance Again," ( published by iUniverse ), encounters ... experience becoming caretaker for her mother, "She Just Wanted to ...
    ... U.S. Pharma can learn from its counterparts in Europe ... While President Obama,s push for a larger government role ... care model developing in the United States may worry some ... growing influence of payers over physician prescription decisions in the ...
    Cached Medicine News:Health News:A Growing Number of Brits Cross the Atlantic for Donor Egg IVF Treatment at Shady Grove Fertility Center 2Health News:A Growing Number of Brits Cross the Atlantic for Donor Egg IVF Treatment at Shady Grove Fertility Center 3Health News:Red Cross, CDC Ready Country for Emergency Threats 2Health News:TGen and USC researchers find genetic markers to help fight diabetes 2Health News:TGen and USC researchers find genetic markers to help fight diabetes 3Health News:Global Med Technologies(R) Licenses Transfusion Software Solution to Nationwide Healthcare System 2Health News:Global Med Technologies(R) Licenses Transfusion Software Solution to Nationwide Healthcare System 3Health News:'She Just Wanted to Dance Again': Navigate the Exchange of Parent-Caregiving Relationships Through Example, Advice 2Health News:Health Care Reform May Force U.S. Pharmaceutical Companies to Overhaul Sales Strategies, Says New Report From ZS Associates and eyeforpharma 2Health News:Health Care Reform May Force U.S. Pharmaceutical Companies to Overhaul Sales Strategies, Says New Report From ZS Associates and eyeforpharma 3Health News:Health Care Reform May Force U.S. Pharmaceutical Companies to Overhaul Sales Strategies, Says New Report From ZS Associates and eyeforpharma 4Health News:Health Care Reform May Force U.S. Pharmaceutical Companies to Overhaul Sales Strategies, Says New Report From ZS Associates and eyeforpharma 5
    The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
    The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
    The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
    Inquire...
    Medicine Products: